Found 0 matching trials
A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma PHASE3 The purpose of this study is to evaluate the efficacy of armodafinil for th...
Show More Location
Pacific Cancer Medical Center, Inc.
Learn More & Join Trial
Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents PHASE2 Evaluate the Safety and Efficacy of Armodafinil Treatment for Patients With...
Show More Location
Northwest Alabama Cancer Center
Learn More & Join Trial
Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia PHASE2 The objective of the study is to evaluate armodafinil as a wakefulness-prom...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue NA To determine whether armodafinil is more effective than placebo in reducing...
Show More Location
Multiple Locations
Learn More & Join Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma PHASE3 This randomized phase III trial studies armodafinil to see how well it work...
Show More Location
Alaska Breast Care and Surgery LLC
Learn More & Join Trial
Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder PHASE2 The primary objective of the study is to determine if armodafinil treatment...
Show More Location
Birmingham Research Group
Learn More & Join Trial
Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer PHASE1 The goal of this clinical research study is to learn if armodafinil can red...
Show More Location
Lyndon B. Johnson General Hospital
Learn More & Join Trial
Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) PHASE1 The goal of this clinical research study is to compare armodafinil, bupropi...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder PHASE3 The primary objective of the study is to determine whether armodafinil trea...
Show More Location
Teva Investigational Site 225
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder PHASE3 The primary objective of the study is to determine whether armodafinil trea...
Show More Location
Birmingham Research Group
Learn More & Join Trial